Skip to content

Clinical trial research on the efficacy in the early diagnosis of electrical impedance tomography (EIT) for chronic obstructive pulmonary disease (COPD)

Clinical trial research on the efficacy in the early diagnosis of electrical impedance tomography (EIT) for chronic obstructive pulmonary disease (COPD)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600117786
Enrollment
Unknown
Registered
2026-01-28
Start date
2024-10-21
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic obstructive pulmonary disease

Interventions

Healthy control group:NA

Sponsors

The Fourth Military Medical University, 986th Hospital of Air Force
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: All kinds of acute and chronic respiratory diseases were excluded in 500 healthy volunteers enrolled in this study. Participants were recruited from November 2024 through November 2029 at the 986 Hospital of the Air Force, and patients had to meet all the following eligibility criteria to be eligible for the study: 1. COPD was diagnosed by spirometry, the airflow is blocked after inhaling the branch expander (FEV 1/FVC is less than 0.7); 2. In a stable period; 3. Be between 40 and 80 years of age; 4. Normal understanding, clear consciousness, can cooperate with the research process.

Exclusion criteria

Exclusion criteria: Patients with any of the following were prohibited from inclusion in the study: 1.Patients with other respiratory conditions such as pulmonary embolism, congestive heart failure, interstitial lung disease exacerbation, pneumonia, or pneumothorax were included; 2.Malignant tumors, autoimmune diseases, systemic infectious diseases, important organ dysfunction; 3.Pleural disease or thoracic deformity; 4.Unable to cooperate with pulmonary function test; 5.Unable to wear the electrode band due to local skin damage.

Design outcomes

Primary

MeasureTime frame
FEV1/FVC;

Secondary

MeasureTime frame
FEV1/FVC abnormal area;global inhomogeneity (GI);coefficients of variation (CV);regional ventilation delay (RVD);

Countries

China

Contacts

Public ContactZhao Ke

The Fourth Military Medical University, 986th Hospital of Air Force

kezhao2001@126.com+86 180 6694 2427

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026